Abiopharma

Appointment of director - Yoav Fridor, effective from 31.5.26

The company’s liability balance as of 31.3.26, by maturity dates

Quarterly report 1 for 2026

Update regarding private placement BONDS 19 - S&P Maalot rating report

SHARE BUY BACK

SHARE BUY BACK

Opening of Trading On Monday, June 01 2026- AFI PROP B18

Register of shareholders, changes and capital status – exercise of employee warrants, exercise of warrants (series 7) and expiration of an employee’s warrants

Q1 report for 2026

Register of shareholders, changes and capital status – issuance of BONDS (Series 18) – supplementary report